arrow
P

Patrick Emond

Sorbonne Universite
H指数:40
被引数:5,464

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrative analysis of circulating biomarkers of colorectal cancer combining mid-infrared spectroscopy and targeted metabolomics

结直肠癌循环生物标志物的整合分析:结合中红外光谱和靶向代谢组学

2026-05-080
OAAI
Functional changes in the gut microbiota are associated with the intestinal phenotype in A20 haploinsufficiency

A20杂合性缺陷中肠道微生物群的功能变化与肠道表型相关

2026-04-160
OAAI
Immunometabolic reprogramming of macrophages by gut microbiota-derived cadaverine controls colon inflammation

肠道菌群衍生的腐胺介导巨噬细胞免疫代谢重编程调控结肠炎症

2025-09-300
OAAI
Longitudinal analysis of fecal tryptophan metabolites and microbiome composition in very preterm infants: impact of birth mode and feeding type

极早产儿粪便色氨酸代谢物和微生物组组成的纵向分析:分娩方式和喂养类型的影响

2025-08-260
OA
Lipidomic signatures of ventilator-associated pneumonia in COVID-19 ARDS patients: a new frontier for diagnostic biomarkers

COVID-19 ARDS患者中与呼吸机相关肺炎相关的脂质组学特征:诊断生物标志物的新前沿

2025-06-050
OAAI
Identification of disease-associated molecular signatures in the Prp-TDP-43A315T mouse model of ALS: Toward preclinical biomarker development

在ALS的Prp-TDP-43A315T小鼠模型中鉴定疾病相关分子标志物:迈向临床前生物标志物开发

2025-06-010
PRE
Metabolomic and Proteomic Profiling of Serum-Derived Extracellular Vesicles from Early-Stage Amyotrophic Lateral Sclerosis Patients

血清源性外泌体在早期肌萎缩侧索硬化症患者的代谢组学和蛋白质组学分析

2025-02-150
PRE
A scoping review evaluating the current state of gut microbiota and its metabolites in valvular heart disease physiopathology
2025-01-100
PRE
Pharmacometabolomics applied to low-dose interleukin-2 treatment in amyotrophic lateral sclerosis
2024-05-210
OAAI
Exploring the Immunomodulatory Potential of Human Milk: Aryl Hydrocarbon Receptor Activation and Its Impact on Neonatal Gut Health

探索人乳的免疫调节潜力: 芳香烃受体激活及其对新生儿肠道健康的影响

2024-05-191
OAAI
Endogenous ether lipids differentially promote tumor aggressiveness by regulating the SK3 channel
2024-05-011
OAAI